Contineum Therapeutics Current Assets

Contineum Therapeutics (CTNM) currently reports a current assets of $250M as of March 2026. That compares with $190M in the prior-year period — up 31.7% year over year. Use the charts on this page to explore Contineum Therapeutics's current assets history and peer comparisons.

Contineum Therapeutics's current assets increased from $190M to $250M — a 31.7% year-over-year increase (period ending March 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Contineum Therapeutics reported $250M in current assets as of March 2026. That compares with $190M in the prior-year period — up 31.7% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current current assets of $250M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Contineum Therapeutics, and consider following CTNM for alerts when major investors trade the stock.